Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020
Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020 Amgen today announced new data from its oncology pipeline in lung cancer will be presented during the 2020 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer taking place virtually from Jan. 28-31, 2021 . Phase 2 data from the CodeBreaK 100 clinical study, evaluating investigational sotorasib in patients with KRAS G12C -mutated advanced non-small cell lung cancer … Amgen (NASDAQ:AMGN) today announced new data from its oncology pipeline in lung cancer will b...
Source: investingnews.com